LIVN חוב לטווח קצר להון עצמי LivaNova

LivaNova PLC (LIVN) enjoys global recognition as a developer of reliable neurostimulators and cardiac surgery equipment that ensure patient safety. Current management strategy focuses on updating the technology stack and divesting inefficient assets to enhance profitability. The market trend visualized in monetary terms, where the indicator stands at 0.00, complements data on a balanced portfolio that combines the production of circulatory systems and high-margin implants.

Balanced cash flows from the production of circulation equipment and neurostimulators at LivaNova PLC (LIVN) enable efficient liquidity management. This metric measures the proportion of liabilities maturing within one year relative to equity, determining the company's ability to cover short-term loans without the risk of a cash crunch. Analyzing the history of short-term debt to equity helps investors assess the business's margin of safety under stress scenarios.